title: Bariatric surgery and end-stage organ failure.
abstract: Morbid obesity increases the risk of complications and allograft failure in transplant patients. Bariatric surgery is both safe and effective in patients with chronic kidney disease and end-stage renal disease, improves eligibility for transplant based on body mass index, and does not affect postoperative immunosuppressant dosing regimens. Bariatric surgery in patients with liver disease has been shown to be safe and effective, although they remain at high risk in the setting of portal hypertension. Sleeve gastrectomy may become increasingly used both pretransplant and posttransplant, as it can result in low complication rates and excellent weight loss, and retains intestinal continuity.
authors.affiliation: Bariatric and Metabolic Surgery Center, Department of Surgery, Houston Methodist Hospital, 6550 Fannin Street, SM 1661, Houston, TX 77030, USA.
authors.forename: Nabil
authors.initials: N
authors.lastname: Tariq
authors.forename: Linda W
authors.initials: LW
authors.lastname: Moore
authors.forename: Vadim
authors.initials: V
authors.lastname: Sherman
mesh_terms: D050110:Bariatric Surgery; D015992:Body Mass Index; D015897:Comorbidity; D005743:Gastrectomy; D006801:Humans; D006975:Hypertension, Portal / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000453:epidemiology*; D016030:Kidney Transplantation; D016031:Liver Transplantation; D009767:Obesity, Morbid / Q000453:epidemiology* / Q000601:surgery; D006435:Renal Dialysis
keywords: Bariatric surgery; Kidney transplantation; Liver transplantation; Obesity